MDMA Asks FDA To Check Reprocessor Websites For Promotional Violations
This article was originally published in The Gray Sheet
Executive Summary
FDA should issue warning letters or "take other appropriate action" to prevent third-party reprocessors of single-use devices from making false or misleading promotional claims on the Internet, the Medical Device Manufacturers Association asserts in a July 22 letter to the agency.